[Federal Register Volume 70, Number 218 (Monday, November 14, 2005)]
[Notices]
[Page 69144]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-22516]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Availability of Government-Owned Inventions; Available 
for Licensing

AGENCY: Department of the Navy, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of the 
availability of exclusive or partially exclusive licenses to practice 
worldwide under the following pending patents. Any license granted 
shall comply with 35 U.S.C. 209 and 37 CFR Part 404. Applications will 
be evaluated utilizing the following criteria: (1) Ability to 
manufacture and market the technology; (2) manufacturing and marketing 
ability; (3) time required to bring technology to market and production 
rate; (4) royalties; (5) technical capabilities; and (6) small business 
status.
    Patent application Serial Number 60/642,771 entitled ``Fimbrial 
Adhesin as Vaccine Against Escherichia Coli'' filed on January 11, 
2005. The present invention relates to the field of inducing an immune 
response against diarrheagenic bacteria including enterotoxigenic 
Escherichia coli using bacterial fimbriae components.
    Patent application Serial Number 60/668,591 entitled ``Recombinant 
Antigens for the Detection of Coxiella Burnetii'' filed on April 6, 
2005. The present invention relates to Coxiella burnetii peptide 
antigens and recombinant DNA encoding the peptides.
    Patent application Serial Number 10/934,686, entitled ``Hospital 
and Clinic Emergency Preparedness Optimization System'' filed on 
September 3, 2004. The present invention relates to hospital and 
ambulatory clinic emergency management systems.
    Patent application Serial Number 60/683,787 entitled ``Anti-Adhesin 
Based Passive Immunoprophylactic'' filed on May 24, 2005. The present 
invention relates to a pharmaceutical useful in conferring passive 
protection against diarrhea caused by enterotoxigenic Esherichia coli.
    Patent application Serial Number 60/709,804 entitled ``A Method for 
the Evaluation of Dengue Virus Therapeutic Agents'' filed on August 22, 
2005. The present invention relates to a method for evaluating the 
immunogenicity and efficacy of vaccine or drug formulations against 
dengue virus using a pig or porcine cells as models of infection and 
pathogenicity.
    Patent application Serial Number 60/715,578 entitled ``Potts 
Reagent Alcohol-Solvent Extraction System'' filed on September 12, 
2005. This invention relates to a method for decontaminating alcohol so 
that it may be recycled in histology and other laboratory settings.
    Patent application serial Number, 60/722,086, entitled 
``Immunogenic Capsule Composition for Use as a Vaccine Against 
Campylobacter Jejuni'' filed September 21, 2005. This invention relates 
to a pharmaceutical useful in conferring protection against diarrhea 
caused by Campylobacter jejuni and a method of administering said 
pharmaceutical.
    Patent application Serial Number 60/627,811 entitled ``Diagnostic 
Assay for Rickettsial prowazekii Disease By Detection of Responsive 
Gene Expression'' filed on November 10, 2004. The present invention 
relates to a method of diagnosing epidemic typhus caused by the 
bacteria Rickettsia prowazekii by analysis of modulation of host gene 
expression. The method contemplates the use of micro-array technology 
for the detection and analysis of gene up or down regulation in 
response to bacterial infection.

DATES: Applications for an exclusive or partially exclusive license may 
be submitted at any time from the date of this notice.

ADDRESSES: Submit application to the Office of Technology Transfer, 
Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 
20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500, telephone 301-319-7428 or e-mail 
at: [email protected].

    Dated: October 31, 2005.
I.C. Le Moyne Jr.,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Alternate Federal Register Liaison Officer.
[FR Doc. 05-22516 Filed 11-10-05; 8:45 am]
BILLING CODE 3810-FF-P